You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SPRY Sale Disclosure
Karas Eric · SEC Form 4 · Filed Jun 12, 2026
Sale
Calculated transaction value
$250K
Karas Eric Chief Commercial Officer
SPRY
ARS Pharmaceuticals
SPRY
Transaction date
Jun 12, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed same day
SPRY daily price context
Close on/before transaction
$9.76
Jun 12, 2026
First close after public filing
$9.81
Jun 15, 2026
30-day return after filing
-21.1%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,000 shares @ $10
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001951287-26-000004
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$287.5K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ars Pharmaceuticals, Inc. SPRY | Exercise | Jun 12, 2026 | $37.5K |
| Ars Pharmaceuticals, Inc. SPRY Current | Sale | Jun 12, 2026 | $250K |
| Ars Pharmaceuticals, Inc. SPRY | Exercise | Jun 12, 2026 | $0 |